Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

UTL-5g

Catalog No. T8845Cas No. 646530-37-2
Alias GBL-5g, 3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-

UTL-5g (3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-) is a novel potential chemoprotective agent, TNF-α inhibitor that reduces cisplatin-induced side effects including nephrotoxicity, hepatotoxicity and hematotoxicity. It lowers elevated levels of AST, ALT, creatinine, BUN, and TNF-α, increases the reduced platelet count in mice, and acts as a novel chemo- and radioprotective agent.

UTL-5g

UTL-5g

Purity: 99.83%
Catalog No. T8845Alias GBL-5g, 3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-Cas No. 646530-37-2
UTL-5g (3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-) is a novel potential chemoprotective agent, TNF-α inhibitor that reduces cisplatin-induced side effects including nephrotoxicity, hepatotoxicity and hematotoxicity. It lowers elevated levels of AST, ALT, creatinine, BUN, and TNF-α, increases the reduced platelet count in mice, and acts as a novel chemo- and radioprotective agent.
Pack SizePriceAvailabilityQuantity
1 mg$72In Stock
5 mg$178In Stock
10 mg$278In Stock
25 mg$563In Stock
50 mg$793In Stock
100 mg$1,130In Stock
1 mL x 10 mM (in DMSO)$218In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "UTL-5g"

Select Batch
Purity:99.83%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
UTL-5g (3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-) is a novel potential chemoprotective agent, TNF-α inhibitor that reduces cisplatin-induced side effects including nephrotoxicity, hepatotoxicity and hematotoxicity. It lowers elevated levels of AST, ALT, creatinine, BUN, and TNF-α, increases the reduced platelet count in mice, and acts as a novel chemo- and radioprotective agent.
In vivo
UTL-5g (GBL-5g) reduces elevated TGF-β and TNF-α levels resulting from lung irradiation[1].
AliasGBL-5g, 3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-
Chemical Properties
Molecular Weight271.1
FormulaC11H8Cl2N2O2
Cas No.646530-37-2
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 27.5 mg/mL (101.44 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.6887 mL18.4434 mL36.8868 mL184.4338 mL
5 mM0.7377 mL3.6887 mL7.3774 mL36.8868 mL
10 mM0.3689 mL1.8443 mL3.6887 mL18.4434 mL
20 mM0.1844 mL0.9222 mL1.8443 mL9.2217 mL
50 mM0.0738 mL0.3689 mL0.7377 mL3.6887 mL
100 mM0.0369 mL0.1844 mL0.3689 mL1.8443 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy UTL-5g | purchase UTL-5g | UTL-5g cost | order UTL-5g | UTL-5g chemical structure | UTL-5g in vivo | UTL-5g formula | UTL-5g molecular weight